{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:29:14Z","timestamp":1747153754205,"version":"3.40.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10753-020-01330-w","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T08:02:53Z","timestamp":1599206573000},"page":"270-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease"],"prefix":"10.1007","volume":"44","author":[{"given":"John","family":"Audley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily F.","family":"Gliniewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kol A.","family":"Zarember","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gal","family":"Wald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Kuhns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry L.","family":"Malech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony F.","family":"Suffredini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Noveck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Dinubile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Levinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Stossel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7081-7620","authenticated-orcid":false,"given":"John I.","family":"Gallin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"1330_CR1","doi-asserted-by":"publisher","first-page":"33179","DOI":"10.1074\/jbc.274.47.33179","volume":"274","author":"HQ Sun","year":"1999","unstructured":"Sun, H.Q., M. Yamamoto, M. Mejillano, and H.L. Yin. 1999. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 274: 33179\u201333182. https:\/\/doi.org\/10.1074\/jbc.274.47.33179.","journal-title":"J Biol Chem"},{"key":"1330_CR2","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1016\/S0021-9258(17)42985-1","volume":"259","author":"HL Yin","year":"1984","unstructured":"Yin, H.L., D.J. Kwiatkowski, J.E. Mole, and F.S. Cole. 1984. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 259: 5271\u20135723.","journal-title":"J Biol Chem"},{"key":"1330_CR3","doi-asserted-by":"publisher","first-page":"29136","DOI":"10.1074\/jbc.M300598200","volume":"278","author":"C Pellieux","year":"2003","unstructured":"Pellieux, C., A. Desgeorges, C.H. Pigeon, C. Chambaz, H. Yin, D. Hayoz, and P. Silacci. 2003. Cap G, a gelsolin family protein modulating protective effects of unidirectional shear stress. J Biol Chem 278: 29136\u201329144. https:\/\/doi.org\/10.1074\/jbc.M300598200.","journal-title":"J Biol Chem"},{"key":"1330_CR4","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1164\/rccm.200409-1185OC","volume":"172","author":"G Candiano","year":"2005","unstructured":"Candiano, G., M. Bruschi, N. Pedemonte, E. Caci, S. Liberatori, L. Bini, C. Pellegrini, M. Vigan\u00f2, B.J. O\u2019Connor, T.H. Lee, et al. 2005. Gelsolin secretion in interleukin-4-treated bronchial epithelia and in asthmatic airways. Am J Respir Crit Care Med 172: 1090\u20131096. https:\/\/doi.org\/10.1164\/rccm.200409-1185OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1330_CR5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199205143262006","volume":"326","author":"WM Lee","year":"1992","unstructured":"Lee, W.M., and R.M. Galbraith. 1992. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326: 1335\u20131341.","journal-title":"N Engl J Med"},{"key":"1330_CR6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1210\/edrv-10-3-294","volume":"10","author":"NE Cooke","year":"1989","unstructured":"Cooke, N.E., and J.G. Haddad. 1989. Vitamin D binding protein (Gc-globulin). Endocr Rev 10: 294\u2013307.","journal-title":"Endocr Rev"},{"key":"1330_CR7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1172\/JCI112634","volume":"78","author":"SE Lind","year":"1986","unstructured":"Lind, S.E., D.B. Smith, P.A. Janmey, and T.P. Stossel. 1986. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J Clin Invest 78: 736\u2013742.","journal-title":"J Clin Invest"},{"issue":"4","key":"1330_CR8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1152\/ajpcell.00510.2006","volume":"292","author":"TM Osborn","year":"2007","unstructured":"Osborn, T.M., C. Dahlgren, J.H. Hartwig, and T.P. Stossel. 2007. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Phys Cell Phys 292 (4): 1323\u20131330.","journal-title":"Am J Phys Cell Phys"},{"key":"1330_CR9","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1152\/ajpcell.00051.2010","volume":"299","author":"R Bucki","year":"2010","unstructured":"Bucki, R., A. Kulakowska, F.J. Byfield, M. Zendzian-Piotrowska, M. Baranowski, M. Marzec, J.P. Winer, N.J. Ciccarelli, J. G\u00f3rski, W. Drozdowski, R. Bittman, and P.A. Janmey. 2010. Plasma gelsolin modulates cellular response to sphingosine 1-phosphate. Am J Phys Cell Phys 299: 1516\u20131523.","journal-title":"Am J Phys Cell Phys"},{"key":"1330_CR10","doi-asserted-by":"crossref","first-page":"13262","DOI":"10.1016\/S0021-9258(18)90687-3","volume":"259","author":"SE Lind","year":"1984","unstructured":"Lind, S.E., and P.A. Janmey. 1984. Human plasma gelsolin binds to fibronectin. J Biol Chem 259: 13262\u201313266.","journal-title":"J Biol Chem"},{"key":"1330_CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.sla.0000201798.77133.55","volume":"243","author":"PF Lee","year":"2006","unstructured":"Lee, P.F., L.R. Drager, T.P. Stossel, F.D. Moore, and S.O. Rogers. 2006. Relationship of plasma gelsolin levels in outcomes of critically ill surgical patients. Ann Surg 243: 399\u2013403.","journal-title":"Ann Surg"},{"key":"1330_CR12","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.burns.2014.02.020","volume":"40","author":"L Xianhui","year":"2014","unstructured":"Xianhui, L., L. Pinglian, W. Xiaojuan, C. Wei, Y. Yong, R. Feng, S. Peng, and X. Gang. 2014. The association between plasma gelsolin level and prognosis of burn patients. Burns 40: 1552\u20131555. https:\/\/doi.org\/10.1016\/j.burns.2014.02.020.","journal-title":"Burns"},{"key":"1330_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025748","volume":"6","author":"LF Huang","year":"2011","unstructured":"Huang, L.F., Y.M. Yao, J.F. Li, N. Dong, C. Liu, Y. Yu, L.X. He, and Z.Y. Sheng. 2011. Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients. PLoS ONE 6: e25748. https:\/\/doi.org\/10.1371\/journal.pone.0025748.","journal-title":"PLoS ONE"},{"key":"1330_CR14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00003246-199704000-00007","volume":"25","author":"E Suhler","year":"1997","unstructured":"Suhler, E., W. Lin, H.L. Yin, and W.N. Lee. 1997. Decreased plasma gelsolin concentration in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med 25: 594\u2013598.","journal-title":"Crit Care Med"},{"key":"1330_CR15","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1164\/ajrccm.160.5.9807137","volume":"160","author":"KC Mounzer","year":"1990","unstructured":"Mounzer, K.C., M. Moncure, Y.R. Smith, and M.J. DiNubile. 1990. Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am J Respir Crit Care Med 160: 1673\u20131681.","journal-title":"Am J Respir Crit Care Med"},{"key":"1330_CR16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00024382-199908000-00002","volume":"12","author":"B Dahl","year":"1999","unstructured":"Dahl, B., F.V. Schiodt, P. Ott, R. Gvozdenovic, H.L. Yin, and W.M. Lee. 1999. Plasma gelsolin is reduced in trauma patients. Shock 12: 102\u2013104.","journal-title":"Shock"},{"key":"1330_CR17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1164\/ajrccm\/138.2.429","volume":"138","author":"SE Lind","year":"1988","unstructured":"Lind, S.E., D.B. Smith, P.A. Janmey, and T.P. Stossel. 1988. Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury. Am Rev Respir Dis 138: 429\u2013434.","journal-title":"Am Rev Respir Dis"},{"key":"1330_CR18","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/0016-5085(92)91731-I","volume":"102","author":"H Ito","year":"1992","unstructured":"Ito, H., H. Kanbe, Y. Kimura, H. Nakamura, E. Hayash, T. Kishimoto, S. Kishimoto, and H. Yamamoto. 1992. Depression of plasma gelsolin during acute liver injury. Gastroenterology 102: 1686\u20131692.","journal-title":"Gastroenterology"},{"issue":"3","key":"1330_CR19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.CCM.0000253815.26311.24","volume":"35","author":"PS Lee","year":"2007","unstructured":"Lee, P.S., A.B. Waxman, K.L. Cotich, S.W. Chung, M.A. Perrella, and T.P. Stossel. 2007. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 35 (3): 849\u2013855.","journal-title":"Crit Care Med"},{"key":"1330_CR20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1152\/japplphysiol.01074.2002","volume":"96","author":"PA Rothenbach","year":"2004","unstructured":"Rothenbach, P.A., B. Dahl, J.J. Schwartz, G.E. O\u2019Keefe, M. Yamamoto, W.M. Lee, J.W. Horton, H.L. Yin, and R.H. Turnage. 2004. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol 96: 25\u201331.","journal-title":"J Appl Physiol"},{"key":"1330_CR21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1742-2094-8-118","volume":"8","author":"QH Zhang","year":"2011","unstructured":"Zhang, Q.H., Q. Chen, J.R. Kang, C. Liu, N. Dong, X.M. Zhu, Z.Y. Sheng, and Y.M. Yao. 2011. Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury. J Neuroinflammation 8: 118.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1330_CR22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","volume":"79","author":"BH Segal","year":"2000","unstructured":"Segal, B.H., T.L. Leto, J.I. Gallin, H.L. Malech, and S.M. Holland. 2000. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79 (3): 170\u2013200.","journal-title":"Medicine (Baltimore)"},{"issue":"27","key":"1330_CR23","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","volume":"363","author":"DB Kuhns","year":"2010","unstructured":"Kuhns, D.B., W.G. Alvord, T. Heller, et al. 2010. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363 (27): 2600\u20132610. https:\/\/doi.org\/10.1056\/NEJMoa1007097.","journal-title":"N Engl J Med"},{"issue":"23","key":"1330_CR24","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/CIRCULATIONAHA.113.006824","volume":"130","author":"CT Sibley","year":"2014","unstructured":"Sibley, C.T., T. Estwick, A. Zavodni, C.Y. Huang, A.C. Kwan, B.P. Soule, D.A. Long Priel, A.T. Remaley, A.K. Rudman Spergel, E.B. Turkbey, D.B. Kuhns, S.M. Holland, H.L. Malech, K.A. Zarember, D.A. Bluemke, and J.I. Gallin. 2014. Assessment of atherosclerosis in chronic granulomatous disease. Circulation 130 (23): 2031\u20132039.","journal-title":"Circulation"},{"key":"1330_CR25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10875-017-0422-6","volume":"37","author":"M Parta","year":"2017","unstructured":"Parta, M., C. Kelly, N. Kwatemaa, N. Theobald, D. Hilligoss, D.B. Kuhns, C. Zerbe, S.M. Holland, S. Malech, and E. Kang. 2017. Allogeneic reduced-intensity hematopoietic stem cell transplantation for chronic granulomatous disease: a single-center prospective trial. J Clin Immunol 37: 548\u2013558.","journal-title":"J Clin Immunol"},{"key":"1330_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/clpt.2014.146","volume":"96","author":"AF Suffredini","year":"2014","unstructured":"Suffredini, A.F., and R.J. Noveck. 2014. Human endotoxin administration as an experimental model in drug development. Clin Pharmacol Ther 96: 418\u2013422. https:\/\/doi.org\/10.1038\/clpt.2014.146.","journal-title":"Clin Pharmacol Ther"},{"key":"1330_CR27","doi-asserted-by":"publisher","first-page":"7.23.1","DOI":"10.1002\/0471142735.im0723s111","volume":"111","author":"DB Kuhns","year":"2015","unstructured":"Kuhns, D.B., D.A.L. Priel, J. Chu, and K.A. Zarember. 2015. Isolation and functional analysis of human neutrophils. Curr Protoc Immunol 111: 7.23.1\u20137.23.16. https:\/\/doi.org\/10.1002\/0471142735.im0723s111.","journal-title":"Curr Protoc Immunol"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-020-01330-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-020-01330-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-020-01330-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T02:12:26Z","timestamp":1630721546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-020-01330-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1330"],"URL":"https:\/\/doi.org\/10.1007\/s10753-020-01330-w","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"type":"print","value":"0360-3997"},{"type":"electronic","value":"1573-2576"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"18 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Susan Levinson and Mark DiNubile are employees of and own stock in BioAegis Therapeutics, Inc. Other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All subjects participated following informed consent and were enrolled in IRB-approved clinical protocols in the NIH Clinical Center in accordance with 45 CFR 46.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}